Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Interstitial lung diseases (ILD) represent an interdisciplinary clinical challenge and are not uncommonly associated with rheumatological diseases. Interstitial lung disease multidisciplinary meetings (ILD-MDM) provide a structured platform for interdisciplinary case discussions and decision making. Despite their great importance in patient care, data on the prevalence, structure and function of ILD-MDM in Germany are lacking.

Objective: The aim of the study was to assess the current status of ILD-MDM in German hospitals to gain insights into their composition, processes and potential for optimization.

Material And Methods: A web-based survey was conducted via SurveyMonkey under the auspices of the German Society for Rheumatology and Clinical Immunology (DGRh) and in collaboration with the German Respiratory Society (DGP) and the German Radiological Society (DRG). A standardized questionnaire captured information on the participating specialist disciplines, organizational structures as well as the content and challenges of local ILD-MDM. The analysis was conducted descriptively.

Results: A total of 125 physicians from 15 federal states in Germany participated. Pulmonologists (93.6%), radiologists (86.4%), rheumatologists (59.2%) and pathologists (57.6%) are the most commonly represented members of ILD-MDM. The majority of ILD-MDMs are conducted either in person (50%) or in a hybrid format (31.5%) and are held on a weekly basis (41.1%). Of all patient cases discussed, two thirds receive a definitive diagnosis and treatment recommendation.

Conclusion: The findings reveal a high acceptance and prevalence of ILD-MDM in Germany but also highlight potential areas for improvement, particularly regarding interdisciplinary participation, technical infrastructure and standardization.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00393-025-01660-wDOI Listing

Publication Analysis

Top Keywords

interstitial lung
12
multidisciplinary meetings
8
lung diseases
8
ild-mdm germany
8
ild-mdm
7
german
5
[national survey
4
survey presence
4
presence multidisciplinary
4
meetings interstitial
4

Similar Publications

Interstitial pneumonia via the oropharyngeal route of infection with Encephalitozoon cuniculi.

PLoS Negl Trop Dis

September 2025

Programa de Patologia Ambiental e Experimental, Universidade Paulista (UNIP), São Paulo, Brasil.

Microsporidia causes opportunistic infections in immunosuppressed individuals. Mammals shed these spores of fungi in feces, urine, or respiratory secretions, which could contaminate water and food, thereby reaching the human body and causing infection. The oral route is the most common route of infection, although experiments have demonstrated that intraperitoneal and intravenous routes may also spread infection.

View Article and Find Full Text PDF

Baricitinib Combination Therapy Demonstrates Significant Improvement in Cardiac Conduction Defects in Rapidly Progressive Systemic Sclerosis: A Case Report.

Open Access Rheumatol

August 2025

Department of Rheumatology and Immunology, the First Affiliated Hospital, Jinan University, Guangzhou, 510632, People's Republic of China.

Objective: To evaluate the efficacy of baricitinib in combination therapy for managing refractory, rapidly progressive systemic sclerosis (SSc) with severe cardiac conduction defects and interstitial lung disease (ILD).

Methods: A 48-year-old male patient with SSc complicated by significant cardiac enlargement, third-degree atrioventricular block, heart failure, progressive ILD, and partial intestinal obstruction was included in the study. Prior treatments with mycophenolate mofetil (MMF), tacrolimus, and cyclophosphamide (CTX) had shown limited efficacy.

View Article and Find Full Text PDF

 is a protozoan parasite that typically causes self-limited diarrhea in healthy individuals but can result in prolonged, severe illness in those who are immunocompromised. While this infection is well recognized in HIV-positive patients, it is less frequently reported in individuals with lupus nephritis on immunosuppressive therapy. We report the case of a 27-year-old man with biopsy-confirmed class IV lupus nephritis who was receiving cyclophosphamide and corticosteroids.

View Article and Find Full Text PDF